P/36/2011 - paediatric investigation plan
Recombinant human granulocyte colony stimulating factor
recombinant human albumin fusion protein
PIPHuman
Teva Pharmaceuticals Europe B.V
info@ratiopharm.de
Germany
Phone: +49 73140202
Fax: +49 7314027832
P/36/2011: EMA decision of 28 January 2011 on the refusal of a product specific waiver for recombinant human granulocyte colony stimulating factor / recombinant human albumin fusion protein (EMEA-001042-PIP01-10) in acc...